Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D0C1EO | ||||
| Former ID | DIB009303 | ||||
| Drug Name | Melanoma vaccine | ||||
| Synonyms | Melanoma vaccine (ALVAC); Melanoma vaccine (ALVAC), sanofi pasteur; Melanoma vaccine (gp100/MAGE-1/MAGE-3/MART-1/NY-ESO-1, ALVAC), sanofi pasteur | ||||
| Drug Type | Vaccine | ||||
| Indication | Melanoma [ICD9: 172; ICD10:C43] | Discontinued in Phase 2 | [547218] | ||
| Company | Sanofi Pasteur | ||||
| Target and Pathway | |||||
| Target(s) | Melanoma associated antigen 1 | Target Info | [531162] | ||
| NY-ESO-1 | Target Info | [531162] | |||
| Melanocytes lineage-specific antigen GP100 | Target Info | [531162] | |||
| Melanoma-associated antigen 3 | Target Info | [531162] | |||
| MART-1 melanoma antigen | Target Info | [531162] | |||
| WikiPathways | Notch Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
